Kay Brune
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kay Brune has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Bertold Renner
Technische Universität Dresden
3 shared publications - Burkhard Hinz
Institute of Pharmacology and Toxicology, Rostock University Medical Center, Schillingallee 70, 18057 Rostock, Germany
2 shared publications A Kaufmann
1 shared publication- Amy P. Abernethy
Flatiron Health, New York, NY
1 shared publication - Andreas Nitsche
Robert Koch Institute, Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS1), Berlin, Germany
1 shared publication - Andreas Pahl
Department of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nürnberg, Fahrstr. 17, D-91054 Erlangen, Germany
1 shared publication
Latest Publications
- 1 January 2012
- Published by Oxford University Press (OUP)
- p. 471-482
Pharmacotherapy of Low Back Pain
- 15 April 2010
- Vol. 152 (15) , 41, 43
[Transdermal fentanyl: what if doctor and pharmacist fail?].
- 28 August 2009
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 134 (36) , 1771-1773
Zyklooxygenasehemmer: Arzneimittelinteraktionen sind unvermeidlich, nur wenige sind (akut) gefährlich
Zyklooxygenasehemmer (NSAR, Coxibe) gehören zu den meist verwendeten Arzneimitteln. Interaktionen sind daher häufig und meist unvermeidlich. Wenige von davon sind allerdings akut lebensgefährlich. Dazu gehören Blutungen aufgrund gehemmter Plättchenaggregationsfähigkeit, thromboembolische Ereignisse aufgrund der Hemmung vaskulärer Schutzfunktionen, Magen-Darm-Perforationen durch erhöhte Blutungsneigung und Verminderung des Organschutzes, akutes Nierenversagen durch Hemmung des Organschutzes bei gleichzeitiger Belastung. Ein akutes Leberversagen ist nur für Paracetamol typisch. In welchem Umfang andere Wirkstoffe dazu beitragen, ist ungeklärt. All diese Risiken können durch die kundige Auswahl der Wirkstoffe und Wirkstoffkombinationen deutlich reduziert werden. Non-steroidal, anti-inflammatory drugs are the most widely used remedies worldwide. Drug interactions are frequent, life threatening ones are rare: Bleeds on the basis of inhibition of platelet aggregation and loss of organ protection (GI-tract), thrombotic events due to loss of vasoprotection and increased propensity for blood coagulation (stroke), acute kidney failure on the basis of loss of kidney protection by prostaglandins together with stress to the organ and/or drugs interfering with the renal blood flow. Acute liver toxicity is typical for acetaminophen. Whether the risk is increased by other hepatoxic drugs, as diclofenac, is uncertain at present. All risks can be reduced considerably by avoiding problematic drug interactions.
- 28 August 2009
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 134 (36) , 1771-1773
Zyklooxygenasehemmer: Arzneimittelinteraktionen sind unvermeidlich, nur wenige sind (akut) gefährlich
Zyklooxygenasehemmer (NSAR, Coxibe) gehören zu den meist verwendeten Arzneimitteln. Interaktionen sind daher häufig und meist unvermeidlich. Wenige von davon sind allerdings akut lebensgefährlich. Dazu gehören Blutungen aufgrund gehemmter Plättchenaggregationsfähigkeit, thromboembolische Ereignisse aufgrund der Hemmung vaskulärer Schutzfunktionen, Magen-Darm-Perforationen durch erhöhte Blutungsneigung und Verminderung des Organschutzes, akutes Nierenversagen durch Hemmung des Organschutzes bei gleichzeitiger Belastung. Ein akutes Leberversagen ist nur für Paracetamol typisch. In welchem Umfang andere Wirkstoffe dazu beitragen, ist ungeklärt. All diese Risiken können durch die kundige Auswahl der Wirkstoffe und Wirkstoffkombinationen deutlich reduziert werden. Non-steroidal, anti-inflammatory drugs are the most widely used remedies worldwide. Drug interactions are frequent, life threatening ones are rare: Bleeds on the basis of inhibition of platelet aggregation and loss of organ protection (GI-tract), thrombotic events due to loss of vasoprotection and increased propensity for blood coagulation (stroke), acute kidney failure on the basis of loss of kidney protection by prostaglandins together with stress to the organ and/or drugs interfering with the renal blood flow. Acute liver toxicity is typical for acetaminophen. Whether the risk is increased by other hepatoxic drugs, as diclofenac, is uncertain at present. All risks can be reduced considerably by avoiding problematic drug interactions.
- 6 May 2009
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 86 (6) , 599-600
Are myocardial infarctions and death in healthy individuals associated with the use of cyclooxygenase inhibitors?
- 6 May 2009
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 86 (6) , 599-600
Are myocardial infarctions and death in healthy individuals associated with the use of cyclooxygenase inhibitors?
- 4 February 2009
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 11 (1) , 36-40
Aspirin and acetaminophen: Should they be available over the counter?
Traditional nonsteroidal anti-inflammatory drugs block cyclooxygenase (COX). They are the most widely used drugs for pain relief. They are indispensable for their effects but are condemned for their adverse drug reactions. Two COX inhibitors, acetaminophen and aspirin, are the most widely used over-the-counter drugs. They have low (but useful) therapeutic activity, but they are endowed with specific risks that are not seen with most other COX inhibitors. Both are lethal if taken in overdose. Each is stigmatized by severe adverse effects. Aspirin results in prolonged inhibition of blood coagulation, and acetaminophen can result in liver toxicity at normal dose and liver failure at higher dose. Both drugs cause many deaths every year. We recommend that the status of both drugs be changed to prescription only. Their continued availability over the counter poses an unacceptable risk to the general population.
- 4 February 2009
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 11 (1) , 36-40
Aspirin and acetaminophen: Should they be available over the counter?
Traditional nonsteroidal anti-inflammatory drugs block cyclooxygenase (COX). They are the most widely used drugs for pain relief. They are indispensable for their effects but are condemned for their adverse drug reactions. Two COX inhibitors, acetaminophen and aspirin, are the most widely used over-the-counter drugs. They have low (but useful) therapeutic activity, but they are endowed with specific risks that are not seen with most other COX inhibitors. Both are lethal if taken in overdose. Each is stigmatized by severe adverse effects. Aspirin results in prolonged inhibition of blood coagulation, and acetaminophen can result in liver toxicity at normal dose and liver failure at higher dose. Both drugs cause many deaths every year. We recommend that the status of both drugs be changed to prescription only. Their continued availability over the counter poses an unacceptable risk to the general population.
- Open Access
- 31 August 2007
- Published by Springer Nature in BMC Immunology
- Vol. 8 (1) , 18
Cytokine profiles of cord and adult blood leukocytes: differences in expression are due to differences in expression and activation of transcription factors
Background: Stem cell transplantation as therapy for hematological disorders is often hampered by severe graft-versus-host-disease. This may be reduced by umbilical cord blood transplantation, an effect that has been attributed to qualitative differences between neonatal and adult T cells. We compared levels of secreted proteins and cytokine mRNA induced in cord blood leukocytes (CBL) and adult blood leukocytes (ABL) by various stimuli.Results: While interleukin-2 (IL-2) levels were similar in CBL and ABL, there was less induction of the Th1 cytokine interferon-γ in CBL. Production of the Th2 cytokines IL-4, IL-5, and IL-13 and the hematopoietic cytokine IL-3 was much lower in CBL versus ABL after T-cell receptor-mediated stimulation, whereas production of GM-CSF was comparable in the 2 cell types. The lower levels of Th1 and Th2 cytokines were maintained in CBL during a 4-day time-course study, while after 12 hours IL-3 and GM-CSF reached in CBL levels similar to those in ABL. For all cytokines except IFNγ, the IC50values for inhibition by cyclosporin A were similar in ABL and CBL. In contrast, there was less expression and activation of transcription factors in CBL. Activation of NF-κB by TPA/ionomycin was detected in ABL but not CBL. Furthermore, there was less expression of the Th subset-specific transcription factors T-bet and c-maf in CBL versus ABL, whereas GATA-3 expression was similar. Expression of T-bet and c-maf correlated with expression of the Th1 and Th2 cytokines, respectively. Time course experiments revealed that T-bet expression was stimulated in both cell types, whereas c-maf and GATA-3 were induced only in ABL.Conclusion: The diminished capability of CBL to synthesize cytokines is probably due to decreased activation of NF-κB, whereas differences in Th subsets are due to differences in regulation of Th lineage-specific transcriptions factors. We propose that the reduced incidence and severity of GvHD after allogeneic transplantation of umbilical CB cells is due to lesser activation of specific transcription factors and a subsequent reduction in production of certain cytokines.
- 31 August 2007
- Published by Springer Nature in BMC Immunology
- Vol. 8 (1) , 18
Open AccessCytokine profiles of cord and adult blood leukocytes: differences in expression are due to differences in expression and activation of transcription factors
Background: Stem cell transplantation as therapy for hematological disorders is often hampered by severe graft-versus-host-disease. This may be reduced by umbilical cord blood transplantation, an effect that has been attributed to qualitative differences between neonatal and adult T cells. We compared levels of secreted proteins and cytokine mRNA induced in cord blood leukocytes (CBL) and adult blood leukocytes (ABL) by various stimuli.Results: While interleukin-2 (IL-2) levels were similar in CBL and ABL, there was less induction of the Th1 cytokine interferon-γ in CBL. Production of the Th2 cytokines IL-4, IL-5, and IL-13 and the hematopoietic cytokine IL-3 was much lower in CBL versus ABL after T-cell receptor-mediated stimulation, whereas production of GM-CSF was comparable in the 2 cell types. The lower levels of Th1 and Th2 cytokines were maintained in CBL during a 4-day time-course study, while after 12 hours IL-3 and GM-CSF reached in CBL levels similar to those in ABL. For all cytokines except IFNγ, the IC50values for inhibition by cyclosporin A were similar in ABL and CBL. In contrast, there was less expression and activation of transcription factors in CBL. Activation of NF-κB by TPA/ionomycin was detected in ABL but not CBL. Furthermore, there was less expression of the Th subset-specific transcription factors T-bet and c-maf in CBL versus ABL, whereas GATA-3 expression was similar. Expression of T-bet and c-maf correlated with expression of the Th1 and Th2 cytokines, respectively. Time course experiments revealed that T-bet expression was stimulated in both cell types, whereas c-maf and GATA-3 were induced only in ABL.Conclusion: The diminished capability of CBL to synthesize cytokines is probably due to decreased activation of NF-κB, whereas differences in Th subsets are due to differences in regulation of Th lineage-specific transcriptions factors. We propose that the reduced incidence and severity of GvHD after allogeneic transplantation of umbilical CB cells is due to lesser activation of specific transcription factors and a subsequent reduction in production of certain cytokines.
- 4 August 2007
- Published by Springer Nature in Der Schmerz
- Vol. 21 (4) , 318-330
Von der Weidenrinde zu den Coxiben
- 4 August 2007
- Published by Springer Nature in Der Schmerz
- Vol. 21 (4) , 318-330
Von der Weidenrinde zu den Coxiben
- 1 January 2007
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 23 (12) , 2985-2995
Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability
Background: Non-steroidal, anti-inflammatory drugs (NSAIDs) are still the most widely used drugs worldwide. The introduction of selective cyclooxygenase (COX)‐2 inhibitors has led to compounds which appear less damaging to the gastrointestinal tract, but possibly more risky to the cardiovascular system than older drugs. None has as yet reached OTC-status.Objective: This situation necessitates an analysis of the characteristics of those older ones which – due to their relative safety – have achieved over-the-counter (OTC) status.Design: The pharmacodynamic and pharmacokinetic characteristics of non-selective COX inhibitors in OTC use were obtained from the literature by systematic search, examined and used to construct a coherent hypothesis why they achieved OTC status, i.e. effectiveness and relative safety at low doses.Results: Pharmacodynamic (COX‐2 preferential, but not selective inhibition) and, more importantly, pharmacokinetic characteristics of some of the older compounds may make them part...
- 1 January 2007
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 23 (12) , 2985-2995
Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability
Background: Non-steroidal, anti-inflammatory drugs (NSAIDs) are still the most widely used drugs worldwide. The introduction of selective cyclooxygenase (COX)‐2 inhibitors has led to compounds which appear less damaging to the gastrointestinal tract, but possibly more risky to the cardiovascular system than older drugs. None has as yet reached OTC-status.Objective: This situation necessitates an analysis of the characteristics of those older ones which – due to their relative safety – have achieved over-the-counter (OTC) status.Design: The pharmacodynamic and pharmacokinetic characteristics of non-selective COX inhibitors in OTC use were obtained from the literature by systematic search, examined and used to construct a coherent hypothesis why they achieved OTC status, i.e. effectiveness and relative safety at low doses.Results: Pharmacodynamic (COX‐2 preferential, but not selective inhibition) and, more importantly, pharmacokinetic characteristics of some of the older compounds may make them part...
- 23 June 2003
- Published by Cambridge University Press (CUP)
- p. 171-187
Nonopioid analgesics